Halozyme Therapeutics, Inc. Liquidation Value

HALO Other

Cash & Equivalents

$133.82M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $133.82M
Total Obligations: -$2.35B
$-2.22B
Per share: $-18.85
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $133.82M
AR: $426.27M
Total Obligations: -$2.35B
$-1.79B
Per share: $-15.23
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $133.82M
AR: $426.27M
Inventory: $176.47M
Total Obligations: -$2.35B
$-1.62B
Per share: $-13.73
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-2.22B$-18.85
Liquid Liquidation Value$-1.79B$-15.23
Operating Liquidation Value$-1.62B$-13.73

Key Components (as of 2025-12-31)

Cash & Equivalents$133.82M
Accounts Receivable$426.27M
Inventory$176.47M
Current Liabilities$177.09M
Long-term Debt$2.14B
Op. Lease Liability$34.57M
Finance LeaseN/A
Shares Outstanding117.8M

Explore all 231 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$133.82M$426.27M$176.47M$20.90M$177.09M$2.14B$34.57MN/A
2025-09-30$419.67M$343.54M$185.80M$15.36M$837.23M$1.51B$28.10MN/A
2025-06-30$61.86M$315.07M$181.50M$18.69M$134.28M$1.51B$28.97MN/A
2025-03-31$176.33M$304.02M$164.87M$20.07M$150.38M$1.51B$29.39MN/A
2024-12-31$115.85M$288.20M$141.86M$10.25M$139.10M$1.51B$30.70MN/A
2024-09-30$154.32M$273.06M$131.41M$12.40M$108.81M$1.50B$30.75MN/A
2024-06-30$187.86M$210.42M$159.31M$15.43M$133.36M$1.50B$30.66MN/A
2024-03-31$164.63M$185.31M$168.54M$13.32M$131.64M$1.50B$31.76MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-17 View
2025-09-30 10-Q 2025-11-03 View
2025-06-30 10-Q 2025-08-05 View
2025-03-31 10-Q 2025-05-06 View
2024-12-31 10-K 2025-02-18 View
2024-09-30 10-Q 2024-10-31 View
2024-06-30 10-Q 2024-08-06 View
2024-03-31 10-Q 2024-05-07 View

Community Notes

Loading notes...

Questions

Loading questions...